CDK12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.941200E-01
Normal-vs-Stage2
4.411400E-01
Normal-vs-Stage3
1.935570E-01
Normal-vs-Stage4
7.098000E-01
Stage1-vs-Stage2
8.781200E-01
Stage1-vs-Stage3
8.809700E-02
Stage1-vs-Stage4
2.083800E-01
Stage2-vs-Stage3
1.432030E-01
Stage2-vs-Stage4
9.894000E-02
Stage3-vs-Stage4
4.637900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.836200E-01
Normal-vs-AfricanAmerican
9.760800E-01
Normal-vs-Asian
3.614000E-01
Caucasian-vs-AfricanAmerican
2.475800E-01
Caucasian-vs-Asian
6.202600E-01
AfricanAmerican-vs-Asian
2.437000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.886400E-01
Normal-vs-Female
4.747000E-01
Male-vs-Female
5.740200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.742000E-01
Normal-vs-Age(41-60Yrs)
7.409200E-01
Normal-vs-Age(61-80Yrs)
3.220600E-01
Normal-vs-Age(81-100Yrs)
2.674800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.631900E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.960400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.852600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.141800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.121550E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.960000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.802400E-01
Normal-vs-Daily Drinker
1.206620E-01
Normal-vs-Weekly Drinker
3.499000E-01
Normal-vs-Occasional Drinker
7.196000E-01
Normal-vs-Social Drinker
7.891600E-01
Non Drinker-vs-Daily Drinker
4.494600E-01
Non Drinker-vs-Weekly Drinker
8.472600E-01
Non Drinker-vs-Occasional Drinker
1.959170E-01
Non Drinker-vs-Social Drinker
1.339020E-01
Daily Drinker-vs-Weekly Drinker
3.833400E-01
Daily Drinker-vs-Occasional Drinker
5.639500E-02
Daily Drinker-vs-Social Drinker
3.154400E-02
Weekly Drinker-vs-Occasional Drinker
3.565000E-01
Weekly Drinker-vs-Social Drinker
2.551200E-01
Occasional Drinker-vs-Social Drinker
8.431600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.233770E-01
Normal-vs-Grade 2
3.126200E-02
Normal-vs-Grade 3
6.203500E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.594400E-01
Grade 1-vs-Grade 3
6.582000E-02
Grade 1-vs-Grade 4
1.233770E-01
Grade 2-vs-Grade 3
3.030200E-01
Grade 2-vs-Grade 4
3.126200E-02
Grade 3-vs-Grade 4
6.203500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.184600E-01
Normal-vs-NonDiabetic
3.564400E-01
Diabetic-vs-NonDiabetic
2.558400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.574200E-01
Normal-vs-NoPancreatitis
3.459600E-01
Pancreatitis-vs-NoPancreatitis
9.667600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.538800E-01
Normal-vs-N1
4.379400E-01
N0-vs-N1
7.590200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.000200E-01
Normal-vs-TP53-NonMutant
6.184200E-01
TP53-Mutant-vs-TP53-NonMutant
1.989980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
